A Comparison of Healthy Days and EuroQol EQ-5D Measures in Two US Adult Samples
- 122 Downloads
Measures of health-related quality of life (HRQOL) have been used to assess the health of populations. This study examined the comparability of two HRQOL measures, the Healthy Days and the EuroQol EQ-5D, in the general US adult population.
Data were from the 2000–2002 Behavioral Risk Factor Surveillance System (BRFSS) and the Medical Expenditure Panel Survey (MEPS). Using a descriptive and ecological design, we compared variations in mean unhealthy days (UD) and EQ-5D scores by sociodemographic and health characteristics, and compared the effect of these variables on both measures using multivariate linear regressions.
Both UD and EQ-5D scores showed worse health for females than males, for blacks and Hispanics than whites, for those with lower educational attainment, for both underweight and overweight people, and for those with worse self-rated health, higher severity of activity limitation, and the presence of any disease. Both measures also had similar effect sizes for these selected variables.
The UD and EQ-5D scores revealed a similar pattern according to sociodemographic variables and clinical factors. This study supports the validity of both sets of measures in assessing the health of adult populations.
KeywordsMEPS BRFSS Health-related Quality-of-life EQ-5D Healthy Days
- Agency for Healthcare Research and Quality (2003). MEPS HC-050 2000 full year consolidated data file. Rockville, MD: AHRQ. Retrieved September 15, 2006 from http://www.meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h50/h50doc.pdf.
- Agency for Healthcare Research and Quality (2006). MEPS fact sheet. Rockville, MD: AHRQ. Retrieved September 15, 2006 from http://www.ahrq.gov/data/mepsix.htm.
- Brooks, R., Rabin, R. E., & de Charro, F. (Eds.) (2003). The measurement and valuation of health status using EQ-5D: A European Perspective. Dordrecht, The Netherlands: Kluwer.Google Scholar
- Centers for Disease Control and Prevention (2000). Measuring Healthy Days. Atlanta, GA: CDC. Retrieved September 14, 2006 from http://www.cdc.gov/hrqol/pdfs/mhd.pdf.
- Cohen, S. B. (2003). Design strategies and innovations in the medical expenditure panel survey. Medical Care, 41(7 Suppl), III5–III12.Google Scholar
- Elliot, M. R., & Davis, W. W. (2005). Obtaining cancer risk factor prevalence estimates in small areas: combining data from two surveys. Applied Statistics, 54(3), 595–609.Google Scholar
- Fleishman, J. A. (2005). Demographic and clinical variations in health status. Rockville (MD): Agency for Healthcare Research and Quality; 2005. MEPS Methodology Report No 14. AHRQ Pub. No. 05-0022.Google Scholar
- Frazier, E. L., Franks, A. L., Sanderson, L. M. (1992). Using Behavioral Risk Factor surveillance data. In: Using chronic disease data: A handbook for public health practitioners. Atlanta, GA: Centers for Disease Control and Prevention, 4, 1–4.17.Google Scholar
- Kind, P., Dolan, P., Gudex, C., & Williams, A. (1998). Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ, 316(7133), 736–741.Google Scholar
- Mokdad, A. H., Stroup, D., & Giles, W. (2003). Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team. MMWR, 52(No. RR-9), 1–12.Google Scholar
- Newschaffer, C. J. (1998). Validation of Behavioral Risk Factor Surveillance System (BRFSS) HRQOL Measures in a Statewide Sample. Atlanta, GA: Centers for Disease Control and Prevention.Google Scholar
- Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.Google Scholar
- SAS Institute Inc (2004). SAS/STAT® User’s Guide, Version 9. Cary, NC: SAS Institute Inc.Google Scholar
- Siderowf, A., Ravina, B., & Glick, H. A. (2002). Preference-based quality-of-life in patients with Parkinson’s disease. Neurology, 59(1), 103–108.Google Scholar
- Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to Score Version Two of the SF-36 Health Survey. Lincoln, RI: QualityMetric Inc.Google Scholar
- Ware, J. E., Snow, K. K., Kosinski, M., & Gandek, B. (1993). SF-36® Health survey manual and interpretation guide. Boston, MA: New England Medical Center, The Health Institute.Google Scholar
- Weintraub, W. S., Foster, J., Culler, S. D., et al. (2004). Methods for the economic and quality of life supplement to the cilostazol for RESTenosis (CREST) trial. Journal of Invasive Cardiology, 16(5), 257–259.Google Scholar
- World Health Organization (1948). Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.Google Scholar